SENS · XBRL financial data

Senseonics Holdings financial statements, every fiscal year

The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (SENS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	5	14	16	—	—	—
Revenue from contracts with customers	1	1	1	22	22	35
Cost of goods and services sold	22	14	14	19	22	19
Gross profit	(17)	(1)	3	3	1	16
Research and development	20	27	40	49	41	32
Selling, general and administrative	41	29	32	30	34	53
General and administrative	21	22	—	—	—	—
Operating income (loss)	(79)	(57)	(69)	(76)	(75)	(68)
Interest expense	16	17	19	11	8	5
Other income (expense)	(0)	(0)	(0)	0	0	(0)
Income tax expense (benefit)	0	0	0	0	0	0
Net income (loss)	(175)	(302)	142	(60)	(79)	(69)
Earnings per share, basic‡ USD per share	(15.40)	(14.40)	6.00	(2.20)	(2.40)	(1.66)
Earnings per share, diluted‡ USD per share	(15.40)	(14.40)	(2.20)	(2.20)	(2.40)	(1.66)
Weighted average shares, basic‡ millions of shares	11	21	23	28	31	42
Weighted average shares, diluted‡ millions of shares	11	21	31	28	31	42

‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (October 2025); filings made before it reported them unadjusted.

Fiscal years (SENS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	18	33	36	76	75	40
Short-term investments	—	96	108	34	—	54
Marketable securities	—	148	120	34	0	54
Accounts receivable	—	—	—	—	6	12
Inventory	5	6	7	9	4	7
Prepaid and other current assets	4	6	7	7	6	4
Total current assets	30	144	161	130	91	118
Property and equipment, net	2	1	1	1	—	—
Right-of-use asset	2	1	3	5	5	4
Total assets	36	199	178	138	100	126
Accounts payable	2	1	0	5	3	4
Total current liabilities	17	18	31	17	39	24
Lease liability, non-current	1	1	3	6	6	5
Total liabilities	177	384	143	65	79	65
Accumulated deficit	(649)	(951)	(809)	(869)	(948)	(1,017)
Total stockholders' equity	(144)	(186)	(3)	36	(17)	61
Total liabilities and equity	36	199	178	138	100	126
Common shares outstanding (cover page)‡ millions of shares	19	23	24	27	33	42

‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (October 2025); filings made before it reported them unadjusted.

Fiscal years (SENS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(175)	(302)	142	(60)	(79)	(69)
Stock-based compensation	7	9	9	9	9	10
Depreciation and amortization	1	1	1	1	1	2
Net cash from operating activities	(67)	(56)	(66)	(70)	(60)	(59)
Net cash from investing activities	(0)	(149)	27	90	33	(53)
Net cash from financing activities	(10)	220	42	20	27	78
Net change in cash	(78)	15	2	40	(1)	(34)

SIC 3823 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3823 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Senseonics Holdings	45	14	(30)*	52.9M	4.7 quarters	Q2 FY26 10-QJun 30, 2026
Pacific Biosciences of California	61	39	(36)*	310.8M	6.7 quarters	Q2 FY26 10-QJun 30, 2026
Cytek Biosciences	67	53	not reported	130.8M	—	Q3 FY26 10-QSep 30, 2026
Mesa Laboratories	31	60	15	5.6M	—	Q1 FY27 10-QJun 30, 2026
Quantum-Si	24	0.3	(18)*	not reported	6.1 quarters	Q2 FY26 10-QJun 30, 2026
Allient	40	164	2*	17.0M	—	Q3 FY26 10-QSep 30, 2026
Frequency Electronics	61	23	2.6	11.3M	—	Q1 FY27 10-QJul 31, 2026
Quanterix	44	33	(5.1)*	47.3M	18.3 quarters	Q2 FY26 10-QJun 30, 2026
EyePoint	110	0.5	(62)*	86.2M	2.9 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.